Clinical Trial Update: Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole [Phase 3]

View source ↗

Summary

Phase 3 trial comparing safety of a single dose of moxidectin versus ivermectin in people living in onchocerciasis-endemic areas, including those co-endemic for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Filariasis
• Onchocerciasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• IVERMECTIN (Ivermectin)
• Moxidectin (moxidectin)

Snippet

Sponsor: Medicines Development for Global Health | Conditions: Onchocerciasis | Phase 3 | Status: COMPLETED | Results posted: 2026-02-05